Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients

Clinical trial NCT07317154 · RECRUITING

Trial details

NCT number: NCT07317154
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Respiratory Papillomatosis

Start date: 2026-09-01
Primary completion: 2027-06-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.